Objective: This study evaluates the impact of an ambient artificial intelligence (AI) documentation platform on clinicians' perceptions of documentation workflow.
Materials And Methods: An anonymous pre- and non-anonymous post-implementation survey evaluated ambulatory clinician perceptions on impact of Abridge, an ambient AI documentation platform. Outcomes included clinical documentation burden, work after-hours, clinician burnout, and work satisfaction. Data were analyzed using descriptive statistics and proportional odds logistic regression to compare changes for concordant questions across pre- and post-surveys. Covariate analysis examined effect of specialty type and duration of AI tool usage.
Results: Survey response rates were 51.9% (93/181) pre-implementation and 74.4% (99/133) post-implementation. Clinician perception of ease of documentation workflow (OR = 6.91, 95% CI: 3.90-12.56, <.001) and in completing notes associated with usage of the AI tool (OR = 4.95, 95% CI: 2.87-8.69, <.001) was significantly improved. Most respondents agreed that the AI tool decreased documentation burden, decreased the time spent documenting outside clinical hours, reduced burnout risk, and increased job satisfaction, with 48% agreeing that an additional patient could be seen if needed. Clinician specialty type and number of days using the AI tool did not significantly affect survey responses.
Discussion: Clinician experience and efficiency was improved with use of Abridge across a breadth of specialties.
Conclusion: An ambient AI documentation platform had tremendous impact on improving clinician experience within a short time frame. Future studies should utilize validated instruments for clinician efficiency and burnout and compare impact across AI platforms.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843214 | PMC |
http://dx.doi.org/10.1093/jamiaopen/ooaf013 | DOI Listing |
Int Dent J
March 2025
Department of Restorative Dentistry, College of Dentistry, Ajman University, Ajman, United Arab Emirates; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Artificial intelligence (AI) holds immense promise in revolutionising dentistry, spanning, diagnostics, treatment planning and educational realms. This narrative review, in two parts, explores the fundamentals and the multifaceted potential of AI in dentistry. The current article explores the profound impact of AI in dentistry, encompassing diagnostic tools, treatment planning, and patient care.
View Article and Find Full Text PDFAppl Clin Inform
March 2025
Department of Emergency Medicine, Indiana University Health Inc, Indianapolis, United States.
Background: Electronic Health Records (EHRs) have significantly impacted healthcare improving access to patient information and enhancing communication among the health care team. However, lack of usability and increased documentation burden has greatly contributed to clinician burnout. Improvements in EHR design that include physician input is critical to develop specific changes that make EHRs less cumbersome; however, it can be challenging to gather input from physicians with full clinical workloads.
View Article and Find Full Text PDFJMIR Med Inform
March 2025
Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, 260-8677, Japan, 81 432262372.
This study demonstrated that while GPT-4 Turbo had superior specificity when compared to GPT-3.5 Turbo (0.98 vs 0.
View Article and Find Full Text PDFJ Infus Nurs
March 2025
Author Affiliations: Takeda Development Center Americas, Inc., Cambridge, Massachusetts (Kim Duff); IQVIA Clinical Research Organization, Milan, Italy (Arianna Soresini); IQVIA Clinical Research Organization, Cambridge, Massachusetts (Nancy Wolf* and Alane Fairchild); IQVIA Clinical Research Organization, Ankara, Turkey (Şükran Altan**); IQVIA Clinical Research Organization, Mexico City, Mexico (Wendy Bencomo); University Clinical Center of Serbia, Belgrade, Serbia (Ivana Ivankovic); University Health Network, University of Toronto, Toronto, Ontario, Canada (Evelyn Sarpong); IQVIA Clinical Research Organization, Warsaw, Poland (Anna Kuczkowska).
Hyaluronidase-facilitated subcutaneous immunoglobulin (fSCIG) 10% offers potential improvements in patient independence and tolerability versus intravenous immunoglobulin (IVIG) when used for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). fSCIG 10% also requires less frequent infusions and fewer infusion sites than conventional subcutaneous immunoglobulin (subcutaneous immunoglobulin without hyaluronidase). The ADVANCE-CIDP 1 study demonstrated fSCIG 10% efficacy and safety in preventing CIDP relapse and positive responses from patients in terms of satisfaction and treatment preference.
View Article and Find Full Text PDFPediatr Int
March 2025
Department of Pediatrics, The Second Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, Hebei, China.
Background: Comprehensive documentation on consecutive years of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in children is lacking. This study aims to provide an in-depth analysis of the clinical profiles of MERS in children across different age groups, focusing on pathogens and recovery time.
Methods: In this retrospective study, 43 patients diagnosed with MERS were enrolled between December 2017 and November 2021.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!